CD4 and hepatocellular carcinoma: In the current study, we investigated the CD3+ T cells, CD4+ T cells, CD8+ T cells, CD68+ macrophages, NK cells, and FOXP3+ Tregs populations in HCC by immunohistochemistry (IHC), and evaluated the relationship between these findings and clinical outcomes.